Lyra Therapeutics (LYRA) Shares Outstanding (2019 - 2025)

Lyra Therapeutics' Shares Outstanding history spans 7 years, with the latest figure at $1.8 million for Q4 2025.

• Shares Outstanding came in at $1.8 million for Q4 2025, up from $1.6 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $49.5 million in Q3 2023 to a low of $1.1 million in Q4 2023.
• The 5-year median for Shares Outstanding is $13.0 million (2021), against an average of $15.2 million.
• Year-over-year, Shares Outstanding surged 144.8% in 2022 and then crashed 97.36% in 2024.
• Lyra Therapeutics' Shares Outstanding stood at $13.0 million in 2021, then skyrocketed by 144.69% to $31.8 million in 2022, then crashed by 96.4% to $1.1 million in 2023, then rose by 14.51% to $1.3 million in 2024, then surged by 35.46% to $1.8 million in 2025.
• Per Business Quant, the three most recent readings for LYRA's Shares Outstanding are $1.8 million (Q4 2025), $1.6 million (Q3 2025), and $1.6 million (Q2 2025).

Peer Comparison